Pioneering the
Science of Tomorrow
Our R&D engine drives continuous innovation — from novel formulation technologies and bioavailability enhancement to clinical research partnerships and regulatory science.
Science-Led. Patient-Focused. Globally Relevant.
At Shomam Pharma, research and development is not a department — it is our core identity. Our 120-strong R&D team works across formulation science, analytical chemistry, regulatory affairs, and clinical research to bring differentiated, affordable medicines to patients worldwide.
End-to-End Drug Development Expertise
From molecule to market — our integrated R&D capabilities span every stage of the pharmaceutical development lifecycle.
Formulation Development
Advanced formulation science covering immediate-release, modified-release, targeted drug delivery, and novel dosage forms. Expertise in solid dispersions, nanotechnology, and lipid-based systems.
Analytical R&D
Comprehensive analytical method development and validation using HPLC, LC-MS/MS, NMR, and dissolution testing. Full ICH-compliant stability studies across accelerated and long-term conditions.
Bioavailability Enhancement
Proprietary technologies to improve oral bioavailability of poorly soluble drugs — including hot-melt extrusion, spray drying, co-crystallisation, and particle engineering.
Regulatory Science
Expert regulatory affairs team with deep experience in CTD dossier preparation, ANDA/NDA filings, WHO prequalification, and EU/US regulatory submissions.
Clinical Research
Bioequivalence and clinical pharmacology studies conducted in partnership with accredited CROs. End-to-end clinical trial management from protocol design to final study report.
Process Chemistry & Scale-Up
API synthesis optimisation, green chemistry initiatives, and robust technology transfer from lab scale to commercial manufacturing with full process validation.
Active Projects Across Therapeutic Areas
Our pipeline reflects our commitment to addressing unmet medical needs with differentiated formulations.
Proprietary Platforms Driving Innovation
Solubility Enhancement Platform
A proprietary hot-melt extrusion and spray-drying platform that improves oral bioavailability of BCS Class II and IV drugs by up to 10-fold.
Controlled Release Technology
Multi-layer matrix and reservoir systems enabling precise drug release profiles — from once-daily oral tablets to pulsatile and chronotherapeutic formulations.
Nanoparticle Drug Delivery
Lipid nanoparticle and polymeric nanoparticle systems for enhanced tissue targeting, improved stability, and reduced side-effect profiles in oncology and CNS indications.
Research Partnerships & Collaborations
We believe the best science emerges from collaboration. Shomam Pharma maintains active research partnerships with leading academic institutions, contract research organisations, and global pharmaceutical companies.
Joint research programmes with IIT Bombay, NIPER, and international universities on novel drug delivery systems.
Accredited CRO partnerships across India, Europe, and the US for bioequivalence, PK/PD, and Phase I–III clinical studies.
Co-development agreements with global innovator companies for generic and specialty pharmaceutical products.
Active engagement with CDSCO, USFDA, EMA, and WHO for regulatory science and policy development.
Interested in a research collaboration?
Our business development and licensing team welcomes enquiries from academic institutions, CROs, and pharmaceutical companies.